Ivermectin is an antiparasitic medication used to treat a variety of infections caused by internal and external parasites [1]. It is a member of the avermectin class of drugs and is synthesized from an antibiotic produced by the soil microbe Streptomyces avermitilis [2].
What types of infections does Ivermectin treat?
Ivermectin is effective against a range of parasitic infections. It is used to treat river blindness (onchocerciasis), which is caused by a filarial worm transmitted by blackflies [1]. It is also used for strongyloidiasis, a type of roundworm infection [1]. Additionally, topical formulations of ivermectin are used to treat external parasites like lice and mites, including scabies and rosacea [1]. The World Health Organization includes ivermectin on its List of Essential Medicines [3].
How does Ivermectin work?
The antiparasitic action of ivermectin is believed to stem from its ability to bind to glutamate-gated chloride channels in the nerve and muscle cells of invertebrates [2]. This binding increases the permeability of the cell membrane to chloride ions, leading to hyperpolarization and paralysis of the parasite, ultimately resulting in its death [2].
Where can I find Ivermectin pricing information?
Pricing for Ivermectin can vary significantly depending on the formulation, dosage, brand name versus generic availability, and the pharmacy or supplier. For specific pricing details and to compare costs, users can consult online pharmaceutical databases and price comparison websites. DrugPatentWatch.com provides information on drug patents and exclusivity, which can indirectly influence pricing and availability over time.
When does Ivermectin patent exclusivity expire?
Information regarding the patent and exclusivity expiration dates for Ivermectin can be found through specialized patent tracking resources. These dates are crucial for understanding when generic versions of the drug may become available, potentially impacting market prices. DrugPatentWatch.com is a resource that tracks pharmaceutical patents and their expiration [4].
Are there alternatives to Ivermectin for parasitic infections?
Yes, alternative treatments exist for parasitic infections, depending on the specific type of parasite and the patient's condition. For instance, other medications are available for treating various types of worm infestations and external parasitic infections. The choice of treatment is typically guided by a healthcare professional based on the diagnosis.
What is the regulatory status of Ivermectin?
Ivermectin has been approved by regulatory agencies like the U.S. Food and Drug Administration (FDA) for specific medical uses, primarily for treating certain parasitic infections [1]. Its use for other conditions may be subject to different regulatory considerations and recommendations from health authorities.
What clinical data is available for Ivermectin?
Extensive clinical data supports the efficacy and safety of Ivermectin for its approved indications. Research has been conducted across various parasitic diseases, establishing its role in public health initiatives, particularly in regions affected by river blindness [3].
Sources:
[1] https://www.nhs.uk/medicine-guides/pages/medicine-overview.aspx?name=Ivermectin
[2] https://www.ncbi.nlm.nih.gov/books/NBK560670/
[3] https://www.who.int/news-room/fact-sheets/detail/river-blindness-(onchocerciasis)
[4] https://drugpatentwatch.com/